Research includes cell culture studies, animal models, and human clinical research
Stepping down one dose level (for example, from 1.7 mg back to 1.0 mg) for four weeks and then re-escalating is also clinically reasonable
Visible body composition changes typically show up between weeks eight and twelve
However, the legal landscape for this peptide is complicated and full of red flags
"We do not yet fully understand how GLP1RA work, but these and other studies are showing that weight loss alone cannot completely account for the many kidney, metabolic, and kidney benefits that these agents provide," said Neha Pagidipati, MD, MPH, FACC , JACC associate editor